PFIZER INC Long-Term Concentrated

Location: New York, NY

CIK: 0000078003 · Show all filings

Period: Q4 2025 (← Previous) (Next →)

Filing Date: Feb 12, 2026

Total Value: $236M (100.0% shares, 0.0% debt)

Holdings (18)

ORIC ORIC PHARMACEUTICALS INC 18.6%
Value $43.98M Shares 5,376,344 Est. Cost $9.18 Unrealized +25.5%
ARVN ARVINAS INC 17.3%
Value $41.01M Shares 3,457,815 Est. Cost $24.30 Unrealized -55.1%
CELC CELCUITY INC 14.7%
Value $34.85M Shares 349,406 Est. Cost $14.11 Unrealized +482.6%
WVE WAVE LIFE SCIENCES LTD 13.5%
Value $31.88M Shares 1,875,000 Est. Cost $13.35 Unrealized -23.9%
ALLO ALLOGENE THERAPEUTICS INC 12.8%
Value $30.18M Shares 22,032,040 Est. Cost $2.47 Unrealized -46.5%
ZURA ZURA BIO LTD 6.6%
Value $15.56M Shares 2,970,022 Est. Cost $3.56 Unrealized +11.0%
PYXS PYXIS ONCOLOGY INC 3.4%
Value $8.088M Shares 7,032,770 Est. Cost $2.88 Unrealized +22.3%
CRBU CARIBOU BIOSCIENCES INC 3.2%
Value $7.458M Shares 4,690,431 Est. Cost $2.01 Unrealized +4.4%
CRDF CARDIFF ONCOLOGY INC 2.9%
Value $6.777M Shares 2,411,575 Est. Cost $3.13 Unrealized -25.7%
BHVN BIOHAVEN LTD 2.4%
Value $5.709M Shares 505,645 Est. Cost $46.66 Unrealized -73.4%
SPRO SPERO THERAPEUTICS INC 2.3%
Value $5.504M Shares 2,362,348 Est. Cost $1.19 Unrealized +95.3%
NXTC NEXTCURE INC 0.9%
Value $2.237M Shares 157,646 Est. Cost $5.23 Unrealized +98.0%
ZNTL ZENTALIS PHARMACEUTICALS INC 0.5%
Value $1.288M Shares 953,834 Est. Cost $3.28 Unrealized -55.6%
QTTB Q32 BIO INC 0.4%
Value $922K Shares 277,777 Est. Cost $31.58 Unrealized -91.0%
ANTX AN2 THERAPEUTICS INC 0.3%
Value $815K Shares 715,295 Est. Cost $1.21 Unrealized -3.7%
BOLT BOLT BIOTHERAPEUTICS INC 0.1%
Value $171K Shares 31,305 Est. Cost $6.62 Unrealized -18.9%
DNA GINKGO BIOWORKS HOLDINGS INC 0.0%
Value $24,332 Shares 2,928 Est. Cost $8.57 Unrealized +25.6%
SENSEONICS HLDGS INC 0.0%
Value $11,983 Shares 2,171 Est. Cost $0.52 Unrealized